We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VMI:NYSEValmont Industries, Inc. Analysis

Data as of 2026-09-19 - not real-time

$474.64

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Valmont Industries, Inc. is neutral at $474.64, with no clear ordering between short and long averages. Over a rolling month the price has lost 3.5%. Relative strength is 44.9 — neutral — and the MACD signal is bullish. The recent range runs from support at $461.97 up to resistance at $490.91.
Valuation screens as undervalued: a P/E of 18.5 sits below the sector average of 27.6. The average analyst target implies 31.6% above today's level. Revenue is growing at 6.5% on a 11.7% profit margin. The 0.65% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 20.4%, a beta of 1.22 and a maximum drawdown of 21.8%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.

Top Market Events

Infrastructure and agriculture equipment manufacturer Valmont Industries NYSE:VMI announced in Q2 CY2026, with sales up...Valmont Industries Inc VMI reports robust sales growth and increased earnings outlook, driven by strong utility...Hosted on MSN1monValmont Industries raises full-year outlook after second-quarter earnings beat VMI Valmont Industries...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 471.75
  • MACD momentum is positive
  • Maximum drawdown of 21.8%

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 18.5 versus sector average of 27.6
  • Trading above the 200-day average of 471.75
  • Analyst targets imply +31.6% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 18.5 versus sector average of 27.6
  • Analyst targets imply +31.6% versus the current price
  • Return on equity of 29.8%

Key Metrics & Analysis

Financial Health

Revenue Growth6.50%
Profit Margin11.70%
P/E Ratio18.5
ROE29.78%
ROA10.77%
Debt/Equity50.68
P/B Ratio5.3
Op. Cash Flow$475.3M
Free Cash Flow$142.8M
Industry P/E27.6

Technical Analysis

TrendNeutral
RSI44.9
Support$461.97
Resistance$490.91
MA 20$476.26
MA 50$491.07
MA 200$471.75
MACDBullish
VolumeStable
Fear & Greed Index94.98

Valuation

Fair Value$82.24
Target Price$624.50
Upside/Downside31.57%
GradeUndervalued
TypeGrowth
Dividend Yield0.65%

Risk Assessment

Beta1.22
Volatility20.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.